EverSource Wealth Advisors
NXTC icon

EverSource Wealth Advisors’s NextCure NXTC Stock Holding History

EverSource Wealth Advisors’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.58K Buy
+1,114
New +$6.2K ﹤0.01% 3239

Other funds holding NXTC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Cardiff Park Advisors
Cardiff Park Advisors Carlsbad, California $1.45B AUM 17.31% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

EverSource Wealth Advisors's NXTC Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in NextCure (NXTC) in Q3 2026: 1,114 shares worth $5.58K. The stake represents ﹤0.01% of the portfolio and ranks #3239 among its holdings.

8 funds tracked by Wall St. Rank hold NXTC as of Q3 2026.

  • EverSource Wealth Advisors held 1,114 shares of NextCure worth $5.58K as of Q3 2026.
  • NextCure was a new EverSource Wealth Advisors position in Q3 2026.
  • NextCure made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #3239 holding.
  • 8 funds tracked by Wall St. Rank held NextCure as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.